These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7230005)

  • 21. [Pharmacokinetics of carsyl (silymarin) in experimental animals].
    Ognianova V; Drensk A; Mikhaĭlova D; Nachev I
    Eksp Med Morfol; 1981; 20(4):214-20. PubMed ID: 7327148
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of verproside after intravenous and oral administration in rats.
    Park EJ; Lee HS; Oh SR; Lee HK; Lee HS
    Arch Pharm Res; 2009 Apr; 32(4):559-64. PubMed ID: 19407974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition kinetics of ML-1035 sulfoxide enantiomers and the prochiral sulfide in rats.
    Kuo BS; Poole JC; Mandagere AK; Hwang KK
    Chirality; 1993; 5(6):428-35. PubMed ID: 8398602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
    Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
    Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal-fetal pharmacokinetics of methanol.
    Pollack GM; Brouwer KL
    Res Rep Health Eff Inst; 1996 Jun; (74):1-48; discussion 49-53. PubMed ID: 11381741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of propranolol on the pharmacokinetics of cyclosporine after intravenous and oral administration to control rats and rats with uranyl nitrate-induced acute renal failure.
    Lee YH; Ku YS
    Res Commun Mol Pathol Pharmacol; 1998 Dec; 102(3):251-64. PubMed ID: 10342912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the pharmacokinetics of dioscin in rat.
    Li K; Tang Y; Fawcett JP; Gu J; Zhong D
    Steroids; 2005 Jul; 70(8):525-30. PubMed ID: 15894036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of water deprivation for 72 hours on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
    Bae SK; Kim YC; Lee JK; Kwon JW; Yoo M; Lee I; Lee MG
    Biopharm Drug Dispos; 2006 Apr; 27(3):147-56. PubMed ID: 16408258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.
    Kim YH; Yoo SD; Kim YS; Lee KH; Lee HS
    Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of (-)-epicatechin in rabbits.
    Chen YA; Hsu KY
    Arch Pharm Res; 2009 Jan; 32(1):149-54. PubMed ID: 19183888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation dependent pharmacokinetics, bioavailability and renal toxicity of a selective cyclooxygenase-1 inhibitor SC-560 in the rat.
    Teng XW; Abu-Mellal AK; Davies NM
    J Pharm Pharm Sci; 2003; 6(2):205-10. PubMed ID: 12935431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L-838417.
    Scott-Stevens P; Atack JR; Sohal B; Worboys P
    Biopharm Drug Dispos; 2005 Jan; 26(1):13-20. PubMed ID: 15578749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
    Shin HS; Bae SK; Lee MG
    Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
    Yang SH; Lee MG
    Biopharm Drug Dispos; 2008 Oct; 29(7):414-26. PubMed ID: 18697186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new physiologically based, segregated-flow model to explain route-dependent intestinal metabolism.
    Cong D; Doherty M; Pang KS
    Drug Metab Dispos; 2000 Feb; 28(2):224-35. PubMed ID: 10640522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability, blood partition, and pharmacokinetics of a new reversible proton pump inhibitor, YJA-20379-1.
    Kim SH; Han KS; Choi WS; Chang MS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):77-84. PubMed ID: 9434317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and bioavailability of metoclopramide nasal spray versus metoclopramide intravenous in healthy volunteers and cancer patients.
    Scaglione F; Scanni A; Tomirotti M; Dimaiuta M; Ferrari P; Fraschini F
    Arzneimittelforschung; 1993 Sep; 43(9):986-8. PubMed ID: 8240464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dystonic reactions and the pharmacokinetics of metoclopramide in children.
    Bateman DN; Craft AW; Nicholson E; Pearson AD
    Br J Clin Pharmacol; 1983 May; 15(5):557-9. PubMed ID: 6860530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.